Bristol-Myers Squibb targets major block of space in East Cambridge
Bristol-Myers Squibb is vetting several property options in East Cambridge, increasingly the office and lab market of choice for many of the largest life sciences companies in the world.
Thu Aug 07, 2014
Court Report -- Part II: August 2014
Medicines Company v. Accord Healthcare, Inc. et al. 1:14-cv-00626; filed July 24, 2014 in the Middle District of North Carolina Infringement of U.S. Patent Nos.
Leica Biosystems and Bristol-Myers Squibb Enter Into a Development...
Leica Biosystems will develop fully automated tissue-based companion diagnostic tests to run on the BONDa automated advanced staining systems Leica Biosystems, today announced an agreement with Bristol-Myers Squibb Company to collaborate on developing companion diagnostics on the Leica BOND system for use as an aid in selecting patients for ... (more)
Tue Aug 05, 2014
Alder Biopharmaceuticals Inc. Reports Second Quarter 2014 Financial And Operating Results
Alder BioPharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today provided recent corporate highlights and reported its financial results for the second quarter ended June 30, 2014.
Allied Minds and Bristol Myers to start 10 new biotechs in next five years
A new partnership being touted by Boston-based Allied Minds will create about 10 biotechs over the next five years - including several in the Bay State - that could then be acquired by New York drug giant Bristol-Myers Squibb .
Mon Aug 04, 2014
Customer Interaction Solutions
Allied Minds and Bristol-Myers Squibb Form New Enterprise to Advance...
Allied Minds and Bristol-Myers Squibb Company today announced the formation of Allied-Bristol Life Sciences LLC, a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university research institutions across the U.S. Allied-Bristol Life Sciences LLC will ... (more)
Fri Aug 01, 2014
Aripiprazole once-monthly for treatment of schizophrenia:...
W. Wolfgang Fleischhacker , MD, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria; Raymond Sanchez , MD, Pamela P. Perry, MS, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey, USA; Na Jin , MS, Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, ... (more)
Thu Jul 31, 2014
AstraZeneca raises earnings outlook as sales climb
British-Swedish drugmaker AstraZeneca, which fought off a takeover from Pfizer earlier this year, raised its 2014 earnings outlook on Thursday and posted rising second-quarter sales.
Wed Jul 30, 2014
Vanguard Health Care Fund's Top Second Quarter Stocks
Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.
The Daily Caller
Selena Gomez Shows Off Skin In Snakeskin Halter Top
The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .
Tue Jul 29, 2014
European Commission Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Bristol-Myers Squibb and Pfizer announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.
Mon Jul 28, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
Bristol-Myers Squibb and Ono Pharmaceutical signed a collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea, and Taiwan.
Fri Jul 25, 2014
Bristol-Myers Squibb Company Taps Bay Area's Redwood City For...
Bristol-Myers Squibb Company Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce July 25, 2014 By Renee Morad , BioSpace.com Breaking News Staff Bristol-Myers Squibb Co.
Thu Jul 24, 2014
Bristol-Myers Squibb Company Appoints As India Country Head
Bristol-Myers Squibb India appointed Jitendra Tyagi as the BMS India country head.
Wed Jul 23, 2014
Customer Interaction Solutions
Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce...
Ono Pharmaceutical Co., Ltd. have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan.
The Motley Fool
Earnings Preview: Bristol-Myers Squibb and Celgene Corporation
Most health care stocks have been experiencing a roller coaster ride so far this year.
Forbes Earnings Preview: Bristol Myers Squibb
Bristol Myers Squibb reports its second-quarter earnings on Thursday, July 24, 2014, and the consensus earnings per share estimate is 45 cents per share.